Investigations of Reproductive Cancers in Women

Inclusion criteria

• Evidence of a personally signed and dated informed consent form indicating that the subject has been informed of all pertinent aspects of the study.
• Willing and able to comply with scheduled visits, study plan, and other procedures.
• Expected to be available for the duration of the study and can be contacted by telephone during study participation.
• Females aged 45 and older (with roughly 80% of enrolled subjects over the age of 50).
• Presence of uterus.
• AUB or PMB being worked up to diagnose the cause of the bleeding

Exclusion criteria

• Investigator site staff members directly involved in the conduct of the study and their family members or subjects who are PinkDx, Inc. employees or their family members.
• Other medical or psychiatric conditions that would increase the risk of study participation in the judgement of the Investigator.
• Women who have had a hysterectomy.
• Women with a known history of endometrial cancer or uterine sarcoma.
• Women who have received prior treatment for endometrial cancer.
• Inability or unwillingness to sign informed consent.
• Clinical suspicion of pregnancy.
• Women who have used a tampon within 7 days of sample collection.